These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18504437)

  • 1. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
    Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
    Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
    Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
    Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
    Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin-C increases lung metastasis by impacting blood vessel invasions.
    Sun Z; Velázquez-Quesada I; Murdamoothoo D; Ahowesso C; Yilmaz A; Spenlé C; Averous G; Erne W; Oberndorfer F; Oszwald A; Kain R; Bourdon C; Mangin P; Deligne C; Midwood K; Abou-Faycal C; Lefebvre O; Klein A; van der Heyden M; Chenard MP; Christofori G; Mathelin C; Loustau T; Hussenet T; Orend G
    Matrix Biol; 2019 Oct; 83():26-47. PubMed ID: 31288084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
    Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
    Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.
    Wang C; Schwab LP; Fan M; Seagroves TN; Buolamwini JK
    Cancer Prev Res (Phila); 2013 May; 6(5):437-47. PubMed ID: 23447563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.
    Worthington J; Bertani M; Chan HL; Gerrits B; Timms JF
    BMC Cancer; 2010 Sep; 10():490. PubMed ID: 20840765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
    Wawrzyniak D; Grabowska M; Głodowicz P; Kuczyński K; Kuczyńska B; Fedoruk-Wyszomirska A; Rolle K
    PLoS One; 2020; 15(8):e0237889. PubMed ID: 32817625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.
    Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH
    Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
    Mehner C; Hockla A; Miller E; Ran S; Radisky DC; Radisky ES
    Oncotarget; 2014 May; 5(9):2736-49. PubMed ID: 24811362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer.
    Suzuki C; Takahashi K; Hayama S; Ishikawa N; Kato T; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
    Mol Cancer Ther; 2007 Feb; 6(2):542-51. PubMed ID: 17308053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms.
    Schoeffner DJ; Matheny SL; Akahane T; Factor V; Berry A; Merlino G; Thorgeirsson UP
    Lab Invest; 2005 May; 85(5):608-23. PubMed ID: 15765121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer.
    Talts JF; Wirl G; Dictor M; Muller WJ; Fässler R
    J Cell Sci; 1999 Jun; 112 ( Pt 12)():1855-64. PubMed ID: 10341205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.
    Pond AC; Herschkowitz JI; Schwertfeger KL; Welm B; Zhang Y; York B; Cardiff RD; Hilsenbeck S; Perou CM; Creighton CJ; Lloyd RE; Rosen JM
    Cancer Res; 2010 Jun; 70(12):4868-79. PubMed ID: 20501844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs.
    Król M; Polańska J; Pawłowski KM; Turowski P; Skierski J; Majewska A; Ugorski M; Morty RE; Motyl T
    J Appl Genet; 2010; 51(1):37-50. PubMed ID: 20145299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.
    Morini M; Astigiano S; Gitton Y; Emionite L; Mirisola V; Levi G; Barbieri O
    BMC Cancer; 2010 Nov; 10():649. PubMed ID: 21108812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism.
    Mohapatra BC; Mirza S; Bele A; Gurumurthy CB; Raza M; Saleem I; Storck MD; Sarkar A; Kollala SS; Shukla SK; Southekal S; Wagner KU; Qiu F; Lele SM; Alsaleem MA; Rakha EA; Guda C; Singh PK; Cardiff RD; Band H; Band V
    Mol Cancer Res; 2022 Sep; 20(9):1391-1404. PubMed ID: 35675041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
    Straume O; Shimamura T; Lampa MJ; Carretero J; Øyan AM; Jia D; Borgman CL; Soucheray M; Downing SR; Short SM; Kang SY; Wang S; Chen L; Collett K; Bachmann I; Wong KK; Shapiro GI; Kalland KH; Folkman J; Watnick RS; Akslen LA; Naumov GN
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8699-704. PubMed ID: 22589302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.